Kinnate Biopharma Price History
| KNTEDelisted Stock | USD 2.96 0.27 8.36% |
If you're considering investing in Kinnate Stock, it is important to understand the factors that can impact its price. As of today, the current price of Kinnate Biopharma stands at 2.96, as last reported on the 29th of December, with the highest price reaching 3.25 and the lowest price hitting 2.95 during the day. We have found twenty-three technical indicators for Kinnate Biopharma, which you can use to evaluate the volatility of the firm. Please verify Kinnate Biopharma's Mean Deviation of 4.52, risk adjusted performance of 0.0044, and Standard Deviation of 5.59 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
Kinnate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Kinnate |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| KNTE |
Based on monthly moving average Kinnate Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kinnate Biopharma by adding Kinnate Biopharma to a well-diversified portfolio.
Kinnate Biopharma Stock Price History Chart
There are several ways to analyze Kinnate Stock price data. The simplest method is using a basic Kinnate candlestick price chart, which shows Kinnate Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Kinnate Stock Price History Data
The price series of Kinnate Biopharma for the period between Mon, Sep 30, 2024 and Sun, Dec 29, 2024 has a statistical range of 1.97 with a coefficient of variation of 14.64. The daily prices for the period are spread out with arithmetic mean of 3.35. The median price for the last 90 days is 3.23.| Open | High | Low | Close | Volume | ||
12/29/2024 | 3.23 | 3.25 | 2.95 | 2.96 | ||
| 07/24/2023 | 3.23 | 3.25 | 2.95 | 2.96 | 157,096 | |
| 07/21/2023 | 3.15 | 3.24 | 3.03 | 3.21 | 195,807 | |
| 07/20/2023 | 3.22 | 3.24 | 3.15 | 3.15 | 112,199 | |
| 07/19/2023 | 3.21 | 3.31 | 3.16 | 3.23 | 203,183 | |
| 07/18/2023 | 3.07 | 3.28 | 3.07 | 3.20 | 135,039 | |
| 07/17/2023 | 3.08 | 3.18 | 3.01 | 3.07 | 186,840 | |
| 07/14/2023 | 3.21 | 3.21 | 2.99 | 3.07 | 246,637 | |
| 07/13/2023 | 3.31 | 3.36 | 3.22 | 3.23 | 132,829 | |
| 07/12/2023 | 3.28 | 3.37 | 3.17 | 3.31 | 186,900 | |
| 07/11/2023 | 3.06 | 3.21 | 3.00 | 3.17 | 270,024 | |
| 07/10/2023 | 2.99 | 3.16 | 2.99 | 3.05 | 216,425 | |
| 07/07/2023 | 3.02 | 3.07 | 2.95 | 2.99 | 193,104 | |
| 07/06/2023 | 3.10 | 3.10 | 2.90 | 3.02 | 267,312 | |
| 07/05/2023 | 2.99 | 3.16 | 2.97 | 3.15 | 221,444 | |
| 07/03/2023 | 3.08 | 3.08 | 2.93 | 3.01 | 204,375 | |
| 06/30/2023 | 3.33 | 3.33 | 3.00 | 3.03 | 376,687 | |
| 06/29/2023 | 3.37 | 3.49 | 3.00 | 3.22 | 350,366 | |
| 06/28/2023 | 3.38 | 3.44 | 3.28 | 3.36 | 116,425 | |
| 06/27/2023 | 3.33 | 3.50 | 3.21 | 3.41 | 241,074 | |
| 06/26/2023 | 3.21 | 3.36 | 3.15 | 3.26 | 357,633 | |
| 06/23/2023 | 3.10 | 3.24 | 2.99 | 3.17 | 3,248,656 | |
| 06/22/2023 | 3.17 | 3.23 | 3.06 | 3.10 | 326,499 | |
| 06/21/2023 | 3.21 | 3.23 | 2.95 | 3.14 | 293,727 | |
| 06/20/2023 | 3.40 | 3.40 | 3.09 | 3.20 | 531,577 | |
| 06/16/2023 | 3.38 | 3.56 | 3.22 | 3.40 | 727,363 | |
| 06/15/2023 | 3.15 | 3.42 | 3.02 | 3.34 | 474,016 | |
| 06/14/2023 | 3.34 | 3.35 | 3.07 | 3.16 | 326,789 | |
| 06/13/2023 | 3.49 | 3.53 | 3.21 | 3.36 | 523,200 | |
| 06/12/2023 | 3.42 | 3.56 | 3.31 | 3.48 | 312,477 | |
| 06/09/2023 | 3.73 | 3.73 | 3.37 | 3.41 | 315,187 | |
| 06/08/2023 | 3.96 | 4.00 | 3.69 | 3.73 | 458,565 | |
| 06/07/2023 | 4.14 | 4.29 | 3.97 | 3.99 | 310,615 | |
| 06/06/2023 | 4.00 | 4.18 | 3.87 | 4.14 | 356,481 | |
| 06/05/2023 | 4.28 | 4.28 | 3.88 | 3.94 | 334,723 | |
| 06/02/2023 | 4.31 | 4.40 | 4.14 | 4.24 | 334,856 | |
| 06/01/2023 | 4.25 | 4.50 | 4.00 | 4.30 | 568,421 | |
| 05/31/2023 | 3.73 | 4.33 | 3.70 | 4.30 | 842,477 | |
| 05/30/2023 | 3.78 | 3.84 | 3.57 | 3.78 | 231,739 | |
| 05/26/2023 | 3.84 | 4.01 | 3.58 | 3.73 | 214,974 | |
| 05/25/2023 | 3.97 | 3.97 | 3.68 | 3.85 | 198,209 | |
| 05/24/2023 | 4.12 | 4.12 | 3.88 | 3.96 | 280,920 | |
| 05/23/2023 | 4.05 | 4.35 | 4.05 | 4.18 | 333,161 | |
| 05/22/2023 | 3.97 | 4.24 | 3.86 | 4.04 | 367,582 | |
| 05/19/2023 | 3.79 | 4.07 | 3.74 | 4.00 | 287,891 | |
| 05/18/2023 | 4.05 | 4.15 | 3.53 | 3.68 | 567,210 | |
| 05/17/2023 | 4.22 | 4.34 | 3.89 | 4.05 | 447,744 | |
| 05/16/2023 | 4.28 | 4.37 | 4.01 | 4.08 | 447,429 | |
| 05/15/2023 | 3.85 | 4.45 | 3.81 | 4.27 | 545,529 | |
| 05/12/2023 | 3.55 | 3.97 | 3.20 | 3.77 | 544,453 | |
| 05/11/2023 | 3.74 | 4.00 | 3.48 | 3.58 | 1,328,642 | |
| 05/10/2023 | 3.40 | 3.56 | 3.16 | 3.48 | 706,579 | |
| 05/09/2023 | 3.19 | 3.40 | 3.06 | 3.34 | 984,923 | |
| 05/08/2023 | 2.94 | 3.11 | 2.80 | 3.10 | 2,837,309 | |
| 05/05/2023 | 2.73 | 2.93 | 2.67 | 2.87 | 1,912,293 | |
| 05/04/2023 | 3.01 | 3.04 | 2.45 | 2.63 | 2,160,457 | |
| 05/03/2023 | 3.00 | 3.07 | 2.72 | 2.91 | 853,627 | |
| 05/02/2023 | 2.70 | 2.86 | 2.53 | 2.85 | 582,157 | |
| 05/01/2023 | 2.55 | 2.74 | 2.48 | 2.65 | 1,431,045 | |
| 04/28/2023 | 2.52 | 2.65 | 2.45 | 2.53 | 634,607 | |
| 04/27/2023 | 2.34 | 2.58 | 2.34 | 2.51 | 364,838 |
About Kinnate Biopharma Stock history
Kinnate Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kinnate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kinnate Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kinnate Biopharma stock prices may prove useful in developing a viable investing in Kinnate Biopharma
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC. Kinnate Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.
Kinnate Biopharma Stock Technical Analysis
Kinnate Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Kinnate Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kinnate Biopharma's price direction in advance. Along with the technical and fundamental analysis of Kinnate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kinnate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0044 | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.19) | |||
| Treynor Ratio | (0.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Kinnate Stock
If you are still planning to invest in Kinnate Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kinnate Biopharma's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |